Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
- 1 March 2000
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 21 (2), 183-197
- https://doi.org/10.1016/s0197-4580(99)00111-6
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Inhibition of Alzheimer's β-Amyloid Induced Vasoactivity and Proinflammatory Response in Microglia by a cGMP-Dependent MechanismExperimental Neurology, 1999
- High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1999
- Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-κB activationLife Sciences, 1999
- Role of protein kinase C α in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993
- Effect of pancreatic type phospholipase A2 on isolated porcine cerebral arteries via its specific binding sitesFEBS Letters, 1992
- Migration of vascular smooth muscle cells by phospholipase A2 via specific binding sitesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAPCell, 1991